These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 18679556

  • 41. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 42. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.
    Gustafsson P, Tsanakas J, Gold M, Primhak R, Radford M, Gillies E.
    Arch Dis Child; 1993 Aug; 69(2):206-11. PubMed ID: 8215522
    [Abstract] [Full Text] [Related]

  • 43. A dose-ranging study of fluticasone propionate administered once daily via multidose powder inhaler to patients with moderate asthma.
    Nathan RA, Li JT, Finn A, Jones R, Payne JE, Wolford JP, Harding SM.
    Chest; 2000 Aug; 118(2):296-302. PubMed ID: 10936116
    [Abstract] [Full Text] [Related]

  • 44. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma.
    Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N.
    Eur Respir J; 2003 Apr; 21(4):633-6. PubMed ID: 12762348
    [Abstract] [Full Text] [Related]

  • 45. Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthma.
    Bernstein DI, Bateman ED, Woodcock A, Toler WT, Forth R, Jacques L, Nunn C, O'Byrne PM.
    J Asthma; 2015 Apr; 52(10):1073-83. PubMed ID: 26291137
    [Abstract] [Full Text] [Related]

  • 46. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
    Mahlab-Guri K, Asher I, Gradstein S, Zung A, Radian-Sade S, Elbirt D, Sthoeger Z.
    J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
    [Abstract] [Full Text] [Related]

  • 47. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group.
    Dahl R, Lundback B, Malo JL, Mazza JA, Nieminen MM, Saarelainen P, Barnacle H.
    Chest; 1993 Nov; 104(5):1352-8. PubMed ID: 8222787
    [Abstract] [Full Text] [Related]

  • 48. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
    Fabbri L, Burge PS, Croonenborgh L, Warlies F, Weeke B, Ciaccia A, Parker C.
    Thorax; 1993 Aug; 48(8):817-23. PubMed ID: 8211872
    [Abstract] [Full Text] [Related]

  • 49. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS, Busse WW, deBoisblanc BP, Berger WE, Noonan MJ, Webb DR, Wolford JP, Mahajan PS, Hamedani AG, Shah T, Harding SM.
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [Abstract] [Full Text] [Related]

  • 50. Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis.
    Masoli M, Weatherall M, Holt S, Shirtcliffe P, Beasley R.
    Eur Respir J; 2006 Nov; 28(5):960-7. PubMed ID: 16737984
    [Abstract] [Full Text] [Related]

  • 51. Inhaled fluticasone propionate by diskus in the treatment of asthma: a comparison of the efficacy of the same nominal dose given either once or twice a day.
    Purucker ME, Rosebraugh CJ, Zhou F, Meyer RJ.
    Chest; 2003 Oct; 124(4):1584-93. PubMed ID: 14555594
    [Abstract] [Full Text] [Related]

  • 52. The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.
    Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, Dorinsky P.
    Ann Allergy Asthma Immunol; 2005 Jul; 95(1):66-71. PubMed ID: 16095144
    [Abstract] [Full Text] [Related]

  • 53. Fluticasone propionate plasma concentration and systemic effect: effect of delivery device and duration of administration.
    Whelan GJ, Blumer JL, Martin RJ, Szefler SJ, Asthma Clinical Research Network and the Pediatric Pharmacology Research Unit Network.
    J Allergy Clin Immunol; 2005 Sep; 116(3):525-30. PubMed ID: 16159619
    [Abstract] [Full Text] [Related]

  • 54. Fluticasone propionate HFA-134a pressurized metered-dose inhaler in adolescents and adults with moderate to severe asthma.
    Pinnas JL, Noonan MJ, Weinstein SF, Chervinsky P, Scott CA, Herje NE, Wu W, Crim C.
    J Asthma; 2005 Dec; 42(10):865-71. PubMed ID: 16393726
    [Abstract] [Full Text] [Related]

  • 55. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 56. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study.
    Agertoft L, Pedersen S.
    Eur Respir J; 1997 Jul; 10(7):1507-12. PubMed ID: 9230238
    [Abstract] [Full Text] [Related]

  • 57. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N, Lundbäck B, Alton M, Rak S, Eivindson A, Bratten G, Kjaersgaard P.
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [Abstract] [Full Text] [Related]

  • 58. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ, Lipworth BJ.
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [Abstract] [Full Text] [Related]

  • 59. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics.
    Wilson AM, McFarlane LC, Lipworth BJ.
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1274-7. PubMed ID: 9351634
    [Abstract] [Full Text] [Related]

  • 60. Efficacy and safety profile of fluticasone furoate administered once daily in the morning or evening: a randomized, double-blind, double-dummy, placebo-controlled trial in adult and adolescent patients with persistent bronchial asthma.
    Medley H, Orozco S, Allen A.
    Clin Ther; 2012 Aug; 34(8):1683-95. PubMed ID: 22796247
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.